Skip to main content
PMC home page
Thorax logoLink to Thorax
. 1999 Jul;54(7):622–624. doi: 10.1136/thx.54.7.622

Effect of a single dose of salmeterol on the increase in airway eosinophils induced by allergen challenge in asthmatic subjects

F Dente 1, L Bancalari 1, E Bacci 1, M Bartoli 1, S Carnevali 1, S Cianchetti 1, F Di 1, D Giannini 1, B Vagaggini 1, R Testi 1, P Paggiaro 1
PMCID: PMC1745521  PMID: 10377209

Abstract

BACKGROUND—The long acting β2 agonist salmeterol is very effective in preventing asthmatic responses to specific stimuli, and this effect could theoretically be due to some anti-inflammatory property in addition to bronchodilator property.
METHODS—The protective effect of a single dose of salmeterol (50 µg) on allergen induced early and late responses and on the associated airway inflammation was investigated in a double blind, placebo controlled, crossover study in 11 atopic asthmatic subjects. Eosinophil percentages and concentrations of eosinophil cationic protein (ECP) in peripheral blood and in hypertonic saline induced sputum were measured 24 hours after allergen inhalation.
RESULTS—Salmeterol effectively inhibited both early and late asthmatic responses in comparison with placebo. Salmeterol also inhibited the increase in the percentage of eosinophils in the sputum 24hours after allergen inhalation (median (range) baseline 6% (1-36), after placebo 31% (5-75), after salmeterol 12% (1-63)). However, the increase in both sputum and serum ECP concentrations 24 hours after allergen challenge was not affected by pretreatment with salmeterol.
CONCLUSIONS—A single dose of salmeterol inhibits the allergen induced airway responses and the increase in sputum eosinophils after allergen challenge.



Full Text

The Full Text of this article is available as a PDF (113.4 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Adelroth E., Rosenhall L., Johansson S. A., Linden M., Venge P. Inflammatory cells and eosinophilic activity in asthmatics investigated by bronchoalveolar lavage. The effects of antiasthmatic treatment with budesonide or terbutaline. Am Rev Respir Dis. 1990 Jul;142(1):91–99. doi: 10.1164/ajrccm/142.1.91. [DOI] [PubMed] [Google Scholar]
  2. Ahlstedt S. Clinical application of eosinophilic cationic protein in asthma. Allergy Proc. 1995 Mar-Apr;16(2):59–62. doi: 10.2500/108854195778771426. [DOI] [PubMed] [Google Scholar]
  3. Bacci E., Cianchetti S., Paggiaro P. L., Carnevali S., Bancalari L., Dente F. L., Di Franco A., Giannini D., Vagaggini B., Giuntini C. Comparison between hypertonic and isotonic saline-induced sputum in the evaluation of airway inflammation in subjects with moderate asthma. Clin Exp Allergy. 1996 Dec;26(12):1395–1400. [PubMed] [Google Scholar]
  4. Cartier A., Thomson N. C., Frith P. A., Roberts R., Hargreave F. E. Allergen-induced increase in bronchial responsiveness to histamine: relationship to the late asthmatic response and change in airway caliber. J Allergy Clin Immunol. 1982 Sep;70(3):170–177. doi: 10.1016/0091-6749(82)90038-0. [DOI] [PubMed] [Google Scholar]
  5. Di Lorenzo G., Morici G., Norrito F., Mansueto P., Melluso M., Purello D'Ambrosio F., Barbagallo Sangiorgi G. Comparison of the effects of salmeterol and salbutamol on clinical activity and eosinophil cationic protein serum levels during the pollen season in atopic asthmatics. Clin Exp Allergy. 1995 Oct;25(10):951–956. doi: 10.1111/j.1365-2222.1995.tb00397.x. [DOI] [PubMed] [Google Scholar]
  6. Giannini D., Carletti A., Dente F. L., Bacci E., Di Franco A., Vagaggini B., Paggiaro P. L. Tolerance to the protective effect of salmeterol on allergen challenge. Chest. 1996 Dec;110(6):1452–1457. doi: 10.1378/chest.110.6.1452. [DOI] [PubMed] [Google Scholar]
  7. Holz O., Richter K., Jörres R. A., Speckin P., Mücke M., Magnussen H. Changes in sputum composition between two inductions performed on consecutive days. Thorax. 1998 Feb;53(2):83–86. doi: 10.1136/thx.53.2.83. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Paggiaro P. L., Dente F. L., Morelli M. C., Bancalari L., Di Franco A., Giannini D., Vagaggini B., Bacci E., Fabbri L. M., Giuntini C. Postallergen inhaled budesonide reduces late asthmatic response and inhibits the associated increase of airway responsiveness to methacholine in asthmatics. Am J Respir Crit Care Med. 1994 Jun;149(6):1447–1451. doi: 10.1164/ajrccm.149.6.8004297. [DOI] [PubMed] [Google Scholar]
  9. Pin I., Gibson P. G., Kolendowicz R., Girgis-Gabardo A., Denburg J. A., Hargreave F. E., Dolovich J. Use of induced sputum cell counts to investigate airway inflammation in asthma. Thorax. 1992 Jan;47(1):25–29. doi: 10.1136/thx.47.1.25. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Pizzichini M. M., Kidney J. C., Wong B. J., Morris M. M., Efthimiadis A., Dolovich J., Hargreave F. E. Effect of salmeterol compared with beclomethasone on allergen-induced asthmatic and inflammatory responses. Eur Respir J. 1996 Mar;9(3):449–455. doi: 10.1183/09031936.96.09030449. [DOI] [PubMed] [Google Scholar]
  11. Rabe K. F., Giembycz M. A., Dent G., Perkins R. S., Evans P., Barnes P. J. Salmeterol is a competitive antagonist at beta-adrenoceptors mediating inhibition of respiratory burst in guinea-pig eosinophils. Eur J Pharmacol. 1993 Feb 9;231(2):305–308. doi: 10.1016/0014-2999(93)90466-u. [DOI] [PubMed] [Google Scholar]
  12. Tilles S. A., Nelson H. S. Long-acting inhaled beta agonists. J Asthma. 1995;32(6):397–404. doi: 10.3109/02770909409077750. [DOI] [PubMed] [Google Scholar]
  13. Twentyman O. P., Finnerty J. P., Harris A., Palmer J., Holgate S. T. Protection against allergen-induced asthma by salmeterol. Lancet. 1990 Dec 1;336(8727):1338–1342. doi: 10.1016/0140-6736(90)92894-n. [DOI] [PubMed] [Google Scholar]
  14. Whelan C. J., Johnson M. Inhibition by salmeterol of increased vascular permeability and granulocyte accumulation in guinea-pig lung and skin. Br J Pharmacol. 1992 Apr;105(4):831–838. doi: 10.1111/j.1476-5381.1992.tb09065.x. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Thorax are provided here courtesy of BMJ Publishing Group

RESOURCES